Abstract
According to evidences from previous family and association studies, it has been claimed that genetic factors are involved in the neuropathogenesis of Schizophrenia disorder. Whether the Val66Met variant of brain-derived neurotrophic factor (BDNF) gene plays any roles in the pathogenesis of this syndrome or could be a potential biomarker for prognosis of this disorder has been a long-standing controversial issue. We performed a meta-analysis restricted to case–control studies and searched Pubmed, PsychInfo, and Google scholar using keywords including ‘association,’ ‘Val66Met,’ ‘BDNF,’ and ‘schizophrenia’ published up to May 1, 2015. A total of 39 studies for schizophrenia were combined by fixed- and random-effects models. The pooled results from the schizophrenia sample indicated no significant evidence for the association of Val/Val and Val/Met genotypes of BDNF gene with schizophrenia, but it was observed that there is an association between Met/Met polymorphism and schizophrenia in Asian, European, and Chinese populations, this means that the risk of schizophrenia in Asian, European, and Chinese populations with Met/Met genotype is, respectively, 9, 26, and 9 %. There was a significant association between BDNF Val66Met polymorphism and schizophrenia in our meta-analysis study. We cannot rule out the possibility that other polymorphisms in the BDNF gene are involved in the pathophysiology of schizophrenia. In addition, more studies should be conducted on the polymorphisms in other genes to elucidate their possible roles in schizophrenia.
Similar content being viewed by others
References
Agartz I, Sedvall GC, Terenius L, Kulle B, Frigessi A, Hall H, Jönsson EG (2006) BDNF gene variants and brain morphology in schizophrenia. Am J Med Genet Part B 141(5):513–523
Agerbo E, Byrne M, Eaton WW, Mortensen PB (2004) Marital and labor market status in the long run in schizophrenia. Arch Gen Psychiatry 61(1):28–33
Anttila S, Illi A, Kampman O, Mattila K, Lehtimäki T, Leinonen E (2005) Lack of association between two polymorphisms of brain-derived neurotrophic factor and response to typical neuroleptics. J Neural Transm 112(7):885–890
Baaré WF, Pol HEH, Boomsma DI, Posthuma D, de Geus EJ, Schnack HG, van Haren NE, van Oel CJ, Kahn RS (2001) Quantitative genetic modeling of variation in human brain morphology. Cereb Cortex 11(9):816–824
Bassett AS, Chow EW, O’Neill S, Brzustowicz LM (2001) Genetic insights into the neurodevelopmental hypothesis of schizophrenia. Schizophr Bull 27(3):417–430
Bersani G, Iannitelli A, Fiore M, Angelucci F, Aloe L (2000) Data and hypotheses on the role of nerve growth factor and other neurotrophins in psychiatric disorders. Med Hypotheses 55(3):199–207
Brans RG, van Haren NE, van Baal GCM, Schnack HG, Kahn RS, Pol HEH (2008) Heritability of changes in brain volume over time in twin pairs discordant for schizophrenia. Arch Gen Psychiatry 65(11):1259–1268
Cardno AG, Gottesman II (2000) Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. Am J Med Genet 97(1):12–17
Cardno AG, Marshall EJ, Coid B, Macdonald AM, Ribchester TR, Davies NJ, Venturi P, Jones LA, Lewis SW et al (1999) Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch Gen Psychiatry 56(2):162–168
Chang H-A, Lu R-B, Shy M-J, Chang C-C, Lee M-S, Huang S-Y (2009) Brain-derived neurotrophic factor Val66Met polymorphism: association with psychopathological symptoms of schizophrenia? J Neuropsychiatry Clin Neurosci 21(1):30–37
Chen Z-Y, Patel PD, Sant G, Meng C-X, Teng KK, Hempstead BL, Lee FS (2004) Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J Neurosci 24(18):4401–4411
Chen Q-Y, Chen Q, Feng G-Y, Wan C-L, Lindpaintner K, Wang L-J, Chen Z-X, Gao Z-S, Tang J-S et al (2006) Association between the brain-derived neurotrophic factor (BDNF) gene and Schizophrenia in the Chinese population. Neurosci Lett 397(3):285–290
Chen S-L, Lee S-Y, Chang Y-H, Chen S-H, Chu C-H, Wang T-Y, Chen P-S, Lee I-H, Yang Y-K et al (2014) The BDNF Val66Met polymorphism and plasma brain-derived neurotrophic factor levels in Han Chinese patients with bipolar disorder and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 51:99–104
de Krom M, Bakker SC, Hendriks J, van Elburg A, Hoogendoorn M, Verduijn W, Sinke R, Kahn R, Adan RA (2005) Polymorphisms in the brain-derived neurotrophic factor gene are not associated with either anorexia nervosa or schizophrenia in Dutch patients. Psychiatr Genet 15(2):81
Dickerson F, Boronow JJ, Stallings C, Origoni AE, Cole SK, Yolken RH (2004) Cognitive functioning in schizophrenia and bipolar disorder: comparison of performance on the repeatable battery for the assessment of neuropsychological status. Psychiatry Res 129(1):45–53
Duman RS, Heninger GR, Nestler EJ (1997) A molecular and cellular theory of depression. Arch Gen Psychiatry 54(7):597–606
Durany N, Michel T, Zöchling R, Boissl KW, Cruz-Sánchez FF, Riederer P, Thome J (2001) Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses. Schizophr Res 52(1):79–86
Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D et al (2003) The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112(2):257–269
Egger M, Smith GD, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634
Gourion D, Goldberger C, Leroy S, Bourdel M-C, Olié J-P, Krebs M-O (2005) Age at onset of schizophrenia: interaction between brain-derived neurotrophic factor and dopamine D3 receptor gene variants. NeuroReport 16(12):1407–1410
Gratacòs M, González JR, Mercader JM, de Cid R, Urretavizcaya M, Estivill X (2007) Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biol Psychiatry 61(7):911–922
Gruber O, Hasan A, Scherk H, Wobrock T, Schneider-Axmann T, Ekawardhani S, Schmitt A, Backens M, Reith W et al (2012) Association of the brain-derived neurotrophic factor val66met polymorphism with magnetic resonance spectroscopic markers in the human hippocampus: in vivo evidence for effects on the glutamate system. Eur Arch Psychiatry Clin Neurosci 262(1):23–31
Han DH, Park DB, Choi TY, Joo SY, Lee MK, Park BRG, Nishimura R, Chu C-C, Renshaw PF (2008) Effects of brain-derived neurotrophic factor–catecholamine-O-methyltransferase gene interaction on schizophrenic symptoms. NeuroReport 19(11):1155–1158
Hashimoto T, Lewis DA (2006) BDNF Val66Met polymorphism and GAD67 mRNA expression in the prefrontal cortex of subjects with schizophrenia. Am J Psychiatry 163(3):534–537
Hashimoto T, Bergen SE, Nguyen QL, Xu B, Monteggia LM, Pierri JN, Sun Z, Sampson AR, Lewis DA (2005) Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. J Neurosci 25(2):372–383
Ho B-C, Milev P, O’Leary DS, Librant A, Andreasen NC, Wassink TH (2006) Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Arch Gen Psychiatry 63(7):731–740
Ho B-C, Psych M, Andreasen NC, Dawson JD, Wassink TH (2007) Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia. Am J Psychiatry 164(12):1890–1899
Hong C-J, Yu YW-Y, Lin C-H, Tsai S-J (2003) An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients. Neurosci Lett 349(3):206–208
Huang T, Lee C (2007) Associations between brain-derived neurotrophic factor G196A gene polymorphism and clinical phenotypes in schizophrenia patients. Chang Gung Med J 30(5):408
Hughes C, Kumari V, Soni W, Das M, Binneman B, Drozd S, O’Neil S, Mathew V, Sharma T (2003) Longitudinal study of symptoms and cognitive function in chronic schizophrenia. Schizophr Res 59(2):137–146
**dal RD, Pillai AK, Mahadik SP, Eklund K, Montrose DM, Keshavan MS (2010) Decreased BDNF in patients with antipsychotic naive first episode schizophrenia. Schizophr Res 119(1):47–51
Jönsson EG, Edman-Ahlbom B, Sillén A, Gunnar A, Kulle B, Frigessi A, Vares M, Ekholm B, Wode-Helgodt B et al (2006) Brain-derived neurotrophic factor gene (BDNF) variants and schizophrenia: an association study. Prog Neuropsychopharmacol Biol Psychiatry 30(5):924–933
Kanazawa T, Glatt SJ, Kia-Keating B, Yoneda H, Tsuang MT (2007) Meta-analysis reveals no association of the Val66Met polymorphism of brain-derived neurotrophic factor with either schizophrenia or bipolar disorder. Psychiatr Genet 17(3):165–170
Koolschijn P, van Haren NE, Bakker SC, Hoogendoorn ML, Pol HEH, Kahn RS (2010) Effects of brain-derived neurotrophic factor Val66Met polymorphism on hippocampal volume change in schizophrenia. Hippocampus 20(9):1010–1017
Lang U, Jockers-Scherübl M, Hellweg R (2004) State of the art of the neurotrophin hypothesis in psychiatric disorders: implications and limitations. J Neural Transm 111(3):387–411
Lieberman JA, Perkins D, Belger A, Chakos M, Jarskog F, Boteva K, Gilmore J (2001) The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches. Biol Psychiatry 50(11):884–897
Lin Z, Su Y, Zhang C, **ng M, Ding W, Liao L, Guan Y, Li Z, Cui D (2013) The interaction of BDNF and NTRK2 gene increases the susceptibility of paranoid schizophrenia. PLoS One 8(9):e74264
Loh H, Tang P, Tee S, Chow T, Cheah Y, Singh S (2012) BDNF and DARPP-32 genes are not risk factors for schizophrenia in the Malay population. Genet Mol Res 11(1):725–730
Lu W, Zhang C, Yi Z, Li Z, Wu Z, Fang Y (2012) Association between BDNF Val66Met polymorphism and cognitive performance in antipsychotic-naive patients with schizophrenia. J Mol Neurosci 47(3):505–510
Maisonpierre PC, Belluscio L, Squinto S, Ip NY, Furth ME, Lindsay RM, Yancopoulos GD (1990) Neurotrophin-3: a neurotrophic factor related to NGF and BDNF. Science 247(4949):1446–1451
Meier S, Mattheisen M, Ripke S, Wray NR (2015) Polygenic Risk Score. Parental socioeconomic status, family history of psychiatric disorders, and the risk for schizophrenia a Danish population-based study and meta-analysis. doi:10.1001/jamapsychiatry.2015.0346
M-m Poo (2001) Neurotrophins as synaptic modulators. Nat Rev Neurosci 2(1):24–32
Naoe Y, Shinkai T, Hori H, Fukunaka Y, Utsunomiya K, Sakata S, Matsumoto C, Shimizu K, Hwang R et al (2007) No association between the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and schizophrenia in Asian populations: evidence from a case–control study and meta-analysis. Neurosci Lett 415(2):108–112
Neves-Pereira M, Cheung J, Pasdar A, Zhang F, Breen G, Yates P, Sinclair M, Crombie C, Walker N et al (2005) BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol Psychiatry 10(2):208–212
Numata S, Ueno S-i, Iga J, Yamauchi K, Hongwei S, Kinouchi S, Shibuya-Tayoshi S, Tayoshi S, Aki H et al (2007) Interaction between catechol-O-methyltransferase (COMT) Val108/158Met and brain-derived neurotrophic factor (BDNF) Val66Met polymorphisms in age at onset and clinical symptoms in schizophrenia. J Neural Transm 114(2):255–259
Park SW, Lee JG, Kong BG, Lee SJ, Lee CH, Kim JI, Kim YH (2009) Genetic association of BDNF val66met and GSK-3β-50T/C polymorphisms with tardive dyskinesia. Psychiatry Clin Neurosci 63(4):433–439
Pełka-Wysiecka J, Wroński M, Jasiewicz A, Grzywacz A, Tybura P, Kucharska-Mazur J, Bieńkowski P, Samochowiec J (2013) BDNF rs 6265 polymorphism and COMT rs 4680 polymorphism in deficit schizophrenia in Polish sample. Pharmacol Rep 65(5):1185–1193
Qian L, Zhao J, Shi Y, Zhao X, Feng G, Xu F, Zhu S, He L (2007) Brain-derived neurotrophic factor and risk of schizophrenia: an association study and meta-analysis. Biochem Biophys Res Commun 353(3):738–743
Ripke S, O’Dushlaine C, Chambert K, Moran JL, Kähler AK, Akterin S, Bergen SE, Collins AL, Crowley JJ et al (2013) Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet 45(10):1150–1159
Schumacher J, Jamra RA, Becker T, Ohlraun S, Klopp N, Binder EB, Schulze TG, Deschner M, Schmäl C et al (2005) Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol Psychiatry 58(4):307–314
Sharma T, Antonova L (2003) Cognitive function in schizophrenia: deficits, functional consequences, and future treatment. Psychiatr Clin N Am 26(1):25–40
Shimizu E, Hashimoto K, Iyo M (2004) Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: the possibility to explain ethnic mental traits. Am J Med Genet Part B 126(1):122–123
Skibinska M, Hauser J, Czerski PM, Leszczynska-Rodziewicz A, Kosmowska M, Kapelski P, Slopien A, Zakrzewska M, Rybakowski JK (2004) Association analysis of brain-derived neurotrophic factor (BDNF) gene Val66Met polymorphism in schizophrenia and bipolar affective disorder. World J Biol Psychiatry 5(4):215–220
Sotiropoulou M, Mantas C, Bozidis P, Marselos M, Mavreas V, Hyphantis T, Antoniou K (2013) BDNF serum concentrations in first psychotic episode drug-naive schizophrenic patients: associations with personality and BDNF Val66Met polymorphism. Life Sci 92(4):305–310
Squassina A, Piccardi P, Del Zompo M, Rossi A, Vita A, Pini S, Mucci A, Galderisi S (2010) NRG1 and BDNF genes in schizophrenia: an association study in an Italian case-control sample. Psychiatry Res 176(1):82–84
Suchanek R, Owczarek A, Paul-Samojedny M, Kowalczyk M, Kucia K, Kowalski J (2013) BDNF val66met polymorphism is associated with age at onset and intensity of symptoms of paranoid schizophrenia in a Polish population. J Neuropsychiatry Clin Neurosci 25(1):88–94
Sun R, Zhu Y, Kuang W, Liu Y, Li S (2011) The G-712A polymorphism of brain-derived neurotrophic factor is associated with major depression but not schizophrenia. Neurosci Lett 489(1):34–37
Sun M-M, Yang L-M, Wang Y, Feng X, Cui K-Y, Liu L-F, Chen Z-Y (2013) BDNF Val66Met polymorphism and anxiety/depression symptoms in schizophrenia in a Chinese Han population. Psychiatr Genet 23(3):124–129
Szeszko P, Lipsky R, Mentschel C, Robinson D, Gunduz-Bruce H, Sevy S, Ashtari M, Napolitano B, Bilder R et al (2005) Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Mol Psychiatry 10(7):631–636
Takahashi T, Suzuki M, Tsunoda M, Kawamura Y, Takahashi N, Tsuneki H, Kawasaki Y, Zhou S-Y, Kobayashi S et al (2008) Association between the brain-derived neurotrophic factor Val66Met polymorphism and brain morphology in a Japanese sample of schizophrenia and healthy comparisons. Neurosci Lett 435(1):34–39
Tan YL, Zhou DF, Cao LY, Zou YZ, Wu GY, Zhang XY (2005) Effect of the BDNF Val66Met genotype on episodic memory in schizophrenia. Schizophr Res 77(2):355–356
Tochigi M, Otowa T, Suga M, Rogers M, Minato T, Yamasue H, Kasai K, Kato N, Sasaki T (2006) No evidence for an association between the BDNF Val66Met polymorphism and schizophrenia or personality traits. Schizophr Res 87(1):45–47
van Os J, Kenis G, Rutten BP (2010) The environment and schizophrenia. Nature 468(7321):203–212
Watanabe Y, Muratake T, Kaneko N, Nunokawa A, Someya T (2006) No association between the brain-derived neurotrophic factor gene and schizophrenia in a Japanese population. Schizophr Res 84(1):29–35
Weickert C, Hyde T, Lipska B, Herman M, Weinberger D, Kleinman J (2003) Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol Psychiatry 8(6):592–610
Xu M-Q, St Clair D, Ott J, Feng G-Y, He L (2007) Brain-derived neurotrophic factor gene C-270T and Val66Met functional polymorphisms and risk of schizophrenia: a moderate-scale population-based study and meta-analysis. Schizophr Res 91(1):6–13
Yi Z, Zhang C, Wu Z, Hong W, Li Z, Fang Y, Yu S (2011) Lack of effect of brain derived neurotrophic factor (BDNF) Val66Met polymorphism on early onset schizophrenia in Chinese Han population. Brain Res 1417:146–150
Zakharyan R, Boyajyan A, Arakelyan A, Gevorgyan A, Mrazek F, Petrek M (2011) Functional variants of the genes involved in neurodevelopment and susceptibility to schizophrenia in an Armenian population. Hum Immunol 72(9):746–748
Zhai J, Yu Q, Chen M, Gao Y, Zhang Q, Li J, Wang K, Ji F, Su Z et al (2013) Association of the brain-derived neurotrophic factor gene G196A rs6265 polymorphisms and the cognitive function and clinical symptoms of schizophrenia. Int J Clin Exp Pathol 6(8):1617
Zhang H, Ozbay F, Lappalainen J, Kranzler HR, van Dyck CH, Charney DS, Price LH, Southwick S, Yang BZ et al (2006) Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer’s disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence. Am J Med Genet Part B 141(4):387–393
Zhang XY, **u MH, Haile CN, Luo X, Xu K, Zhang HP, Zuo L, Zhang Z, Zhang X et al (2012) Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls. Hum Genet 131(7):1187–1195
Zhou DH, Yan QZ, Yan XM, Li CB, Fang H, Zheng YL, Zhang CX, Yao HJ, **u MH et al (2010) The study of BDNF Val66Met polymorphism in Chinese schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry 34(6):930–933
Acknowledgments
This study was supported by the Isfahan University of Medical Sciences, Isfahan, Iran.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors report no conflict of interest.
Rights and permissions
About this article
Cite this article
Kheirollahi, M., Kazemi, E. & Ashouri, S. Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphism and Risk of Schizophrenia: A Meta-analysis of Case–Control Studies. Cell Mol Neurobiol 36, 1–10 (2016). https://doi.org/10.1007/s10571-015-0229-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10571-015-0229-z